Profhilo is an injectable skin treatment made from highly purified hyaluronic acid (HA). Its not a traditional filler that adds volume. Instead its designed to hydrate, stimulate collagen and elastin production, and remodel skin quality from within. HA attracts and holds water which plumps and hydrates tissue while triggering fibroblasts to make new collagen and elastin. This gives a gradual improvement in skin firmness, elasticity, and texture.
Our dataset currently has 16 clinic(s), with approximately 359 reviews and an average rating of 4.642857143.
Medical Infrastructure:
- Primary care led system under Health and Social Care (HSC) Northern Ireland
- Acute services linked to South West Acute Hospital (Western Health and Social Care Trust)
- Presence of NHS GP practices and independent aesthetic providers
Local Aethetics Market:
- Developing but saturated at micro-market scale
- Strong nurse-led aesthetic presence
Profhilo itself has regulatory approvals (MHRA and FDA reported in some sources) confirming it's safety profile as an injectable HA treatment. However specific NICE procedural guidance may be limited, and UK practice of cosmetic injectables lacks strict regulation on who can provide treatments, so clinician judgement and adherence to best practices matter.
Local regulatory authority:
- Regulation and Quality Improvement Authority (RQIA) for Northern Ireland
- General Medical Council (GMC) for doctors
- Nursing and Midwifery Council (NMC) for nurse prescribers
Private insurance usage locally:
- Limited use of private insurance for aesthetics
- Dermatology may be privately self-funded or NHS-referred depending on indication
Cosmetic finance availability:
- Primarily pay-per-treatment
- Limited evidence of structured third-party finance penetration compared to major UK cities
Current average rating citywide: 4.642857143